logo
  

Givaudan Q3 Group Sales Rise; Sees Organic Sales Growth Under 2025 Strategy

Givaudan AG (GVDBF.PK), a Swiss maker of flavors, fragrances, and cosmetic ingredients, on Tuesday reported that its third-quarter group sales grew 6.7 percent to 1.81 billion Swiss francs from last year's 1.69 billion francs.

Like-for-like sales went up 5.8 percent.

In the quarter, Fragrance & Beauty sales were 843 million francs, a growth of 7.1 percent on a reported basis and 7.9 percent on LFL basis.

Taste & Wellbeing sales were 965 million francs, up 6.4 percent on reported basis, and the LFL sales growth was 3.9 percent.

With higher input costs in 2022, the company said it is fully on track in implementing price increases in collaboration with its customers to fully compensate for the increases in input costs.

Looking ahead, under its 2025 strategy, the company aims to achieve organic sales growth of 4-5 percent on a like-for-like basis and free cash flow of at least 12 percent, both measured as an average over the five-year period strategy cycle.

Over the long term, the company expects doubling its business through creations that contribute to happier, healthier lives by 2030, and becoming climate positive before 2050.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Drug major Pfizer Inc. reported Tuesday higher earnings in its fourth quarter, above market estimates, and an all-time high revenues in its fiscal 2022. Meanwhile, the company projects sharply lower adjusted earnings and revenues in its fiscal 2023, below Wall Street estimates, reflecting projected decline for COVID-19 products. In pre-market activity on the NYSE, Pfizer shares were losing around Oil major Exxon Mobil Corp. (XOM) reported Tuesday that fourth-quarter net income was $12.75 billion or $3.09 per share, up from $8.87 million or $2.08 per share in the prior-year quarter. Excluding special items, adjusted earnings were $3.40 per share, compared to $2.05 per share in the prior-year... La Mirada, California-based Daiso California LLC is recalling certain Matsunaga Mini Shiruko Sand Biscuits citing undeclared soy, an allergen, the U.S. Food and Drug Administration said. The recall incolves Matsunaga Mini Shiruko Sand Biscuits with sku 4902773016966, packaged in four pink and cream bags chained together. Each individual serving is 25g for an entire product weight of 100g.
RELATED NEWS
Follow RTT